Skip to Content

CME Group Inc Class A

CME: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$315.00GjwmyVkwgmlgjy

CME Delivers Another Strong Quarter as Volatility Drives High Trading Volume in Third Quarter

Wide-moat CME group reported solid third-quarter earnings that were broadly in line with our expectations as it continues to benefit from volatile markets in 2022. Revenue increased 10.6% from last year to $1.23 billion, though was effectively flat sequentially. Net income fell from $926.5 million last year to $679.6 million as the company laps a $430 million one-time gain during last year’s quarter. As we incorporate these results, we do not expect to make any material changes to our $220 fair value estimate for CME.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of CME so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center